Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice
Boukelmoune, Nabila; Laumet, Geoffroy; Tang, Yongfu; Ma, Jiacheng; Mahant, Itee; Nijboer, Cora; Benders, Manon; Kavelaars, Annemieke; Heijnen, Cobi J
(2021) Brain, Behavior, and Immunity, volume 93, pp. 43 - 54
(Article)
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequently reported adverse effects of cancer treatment. CIPN often persists long after treatment completion and has detrimental effects on patient's quality of life. There are no efficacious FDA-approved drugs for CIPN. We recently demonstrated that nasal administration of mesenchymal stem cells
... read more
(MSC) reverses the cognitive deficits induced by cisplatin in mice. Here we show that nasal administration of MSC after cisplatin- or paclitaxel treatment- completely reverses signs of established CIPN, including mechanical allodynia, spontaneous pain, and loss of intraepidermal nerve fibers (IENF) in the paw. The resolution of CIPN is associated with normalization of the cisplatin-induced decrease in mitochondrial bioenergetics in DRG neurons. Nasally administered MSC enter rapidly the meninges of the brain, spinal cord and peripheral lymph nodes to promote IL-10 production by macrophages. MSC-mediated resolution of mechanical allodynia, recovery of IENFs and restoration of DRG mitochondrial function critically depends on IL-10 production. MSC from IL-10 knockout animals are not capable of reversing the symptoms of CIPN. Moreover, WT MSC do not reverse CIPN in mice lacking IL-10 receptors on peripheral sensory neurons. In conclusion, only two nasal administrations of MSC fully reverse CIPN and the associated mitochondrial abnormalities via an IL-10 dependent pathway. Since MSC are already applied clinically, we propose that nasal MSC treatment could become a powerful treatment for the large group of patients suffering from neurotoxicities of cancer treatment.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Cisplatin, Interleukin-10 (IL-10), Meninges, Mesenchymal Stem Cells (MSC), Mitochondria, Peripheral neuropathy, Sensory neurons, Endocrine and Autonomic Systems, Behavioral Neuroscience, Immunology, Journal Article
ISSN: 0889-1591
Publisher: Academic Press Inc.
Note: Funding Information: This work was supported by the National Institutes of Health [Grants R01CA208371, RO1 NS073939 and RO1CA227064]; and the National Institutes of Health, Cancer Center Support Grant [P30 CA016672]. N.B. A.K. and C.J.H designed research; N.B. G.L. Y.T. J.M. S.K.S and I.M performed research and analyzed data; N.B. A.K. and C.J.H wrote the paper; C.N. and M.B. reviewed and edited the manuscript. Funding Information: This work was supported by National Institute of Health Grants R01CA208371 , RO1 NS073939 and RO1CA227064 . Publisher Copyright: © 2020 Elsevier Inc. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
(Peer reviewed)